Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
Myrna Nahas, Jacalyn Rosenblatt(Beth Israel Deaconess Medical Center), Jon Arnason(Beth Israel Deaconess Medical Center), Robin Joyce(Beth Israel Deaconess Medical Center), Rebecca Karp Leaf(California University of Pennsylvania), Vincent T. Ho(Dana-Farber Cancer Institute), Leandra Cole(Beth Israel Deaconess Medical Center), Haesook T. Kim(Dana-Farber Cancer Institute), David Avigan(Beth Israel Deaconess Medical Center), Joseph H. Antin(Dana-Farber Cancer Institute), Jeremy Stewart(Harvard University), Malgorzata McMasters(Beth Israel Deaconess Medical Center), Robert J. Soiffer(Dana-Farber Cancer Institute), Edwin P. Alyea(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mary Paty Bryant(Beth Israel Deaconess Medical Center), Dimitrios Tzachanis(Dana-Farber Cancer Institute), Salvia Jain(Broad Institute), Emma Logan(Beth Israel Deaconess Medical Center), Athalia R. Pyzer, Shuli Li(Unknown), Dina Stroopinsky(Beth Israel Deaconess Medical Center), Susan Stephenson(Harvard University), James D. Levine(Beth Israel Deaconess Medical Center), Ayad Hamdan(University of California San Diego), Josie Bazemore(Dana-Farber Cancer Institute), Abigail Washington(Beth Israel Deaconess Medical Center), Amy Joyce(Dana-Farber Cancer Institute)
Cited by 48
Related Papers
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
|Journal of Clinical Oncology|2002|1.2k
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
|New England Journal of Medicine|2011|1.1k